Kontafarma China Holdings Ltd's market cap is currently HK$156.20M. The company's EPS TTM is HK$-0.011; its P/E ratio is ―; Kontafarma China Holdings Ltd is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	HK$ 809.11M	HK$ 894.06M	HK$ 961.09M	HK$ 1.01B	HK$ 1.48B
Gross Profit	HK$ 471.29M	HK$ 506.22M	HK$ 482.89M	HK$ 555.75M	HK$ 748.71M
Operating Income	HK$ 0.00	HK$ -47.06M	HK$ -42.56M	HK$ 40.39M	HK$ 305.81M
EBITDA	HK$ 76.63M	HK$ 26.93M	HK$ 112.18M	HK$ 156.31M	HK$ 419.17M
Net Income	HK$ -28.84M	HK$ -109.74M	HK$ -4.55M	HK$ -20.09M	HK$ 65.21M
Balance Sheet
Cash & Short-Term Investments	HK$ 87.66M	HK$ 142.59M	HK$ 183.96M	HK$ 194.79M	HK$ 236.39M
Total Assets	HK$ 1.73B	HK$ 2.12B	HK$ 2.56B	HK$ 2.54B	HK$ 4.00B
Total Debt	HK$ 333.82M	HK$ 590.72M	HK$ 728.95M	HK$ 751.29M	HK$ 898.04M
Net Debt	HK$ 256.16M	HK$ 468.13M	HK$ 560.99M	HK$ 585.48M	HK$ 749.74M
Total Liabilities	HK$ 665.39M	HK$ 964.16M	HK$ 1.22B	HK$ 1.19B	HK$ 2.08B
Stockholders' Equity	HK$ 1.06B	HK$ 1.10B	HK$ 1.19B	HK$ 1.21B	HK$ 1.41B
Cash Flow
Free Cash Flow	HK$ 12.92M	HK$ -53.84M	HK$ -49.31M	HK$ 26.03M	HK$ -64.57M
Operating Cash Flow	HK$ 37.12M	HK$ -2.17M	HK$ 75.07M	HK$ 206.93M	HK$ 25.67M
Investing Cash Flow	HK$ 144.14M	HK$ 121.53M	HK$ 23.24M	HK$ -206.12M	HK$ 112.37M
Financing Cash Flow	HK$ -198.81M	HK$ -137.33M	HK$ -99.80M	HK$ 19.10M	HK$ -82.05M

Currency in HKD

Kontafarma China Holdings Ltd Earnings and Revenue History

Income Statement >

Kontafarma China Holdings Ltd Debt to Assets

Balance Sheet >

Kontafarma China Holdings Ltd Cash Flow

Cash Flow >

Kontafarma China Holdings Ltd Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing